Skip to main content

Table 4 Potential factors influencing the prescription of oseltamivir to 2,242 influenza patients not at high risk

From: Prescription of antiviral drugs during the 2009 influenza pandemic: an observational study using electronic medical files of general practitioners in the Netherlands

 

Prescription of oseltamivir, n of patients (%)

Univariate analysis

Variable

No

 

Yes

 

OR

(95% CI)

Patient characteristics

      

Gender

      

 Male

1,039

(47.5)

29

(52.7)

ref

-

 Female

1,148

(52.5)

26

(47.3)

0.81

(0.47 to 1.39)

Age at diagnosis

      

 2 to 14 yrs

819

(37.4)

16

(29.1)

0.69

(0.37 to 1.29)

 15 to 24 yrs

411

(18.8)

12

(21.8)

1.03

(0.52 to 2.06)

 25 to 59 yrs

957

(43.8)

27

(49.1)

ref

-

Chronic health condition not at high risk

      

 No

1,754

(80.2)

45

(81.8)

ref

-

 Yes

433

(19.8)

10

(18.2)

0.90

(0.45 to 1.80)

Number of contacts with GP in 2009

      

 <6

1,468

(67.1)

36

(65.5)

ref

-

 6 or more

719

(32.9)

19

(34.5)

1.08

(0.61 to 1.89)

Total number of prescriptions in 2009*

      

 <8

1,888

(86.3)

41

(74.5)

ref

-

 8 or more

299

(13.7)

14

(25.5)

2.16

(1.16 to 4.00)

Practice characteristics

      

Type of practice

      

 Solo practice

706

(32.3)

24

(43.6)

ref

-

 Duo practice

437

(20.0)

8

(14.6)

0.54

(0.24 to 1.21)

 Group practice

1,044

(47.7)

23

(41.8)

0.65

(0.36 to 1.16)

Dispensing practice

101

(4.6)

2

(3.6)

0.78

(0.19 to 3.24)

Urbanicity practice location

      

 (Very) strongly urban

1,116

(51.0)

27

(49.1)

0.84

(0.42 to 1.68)

 Moderately urban

418

(19.1)

12

(21.8)

ref

-

 Mildly/not urban

653

(29.9)

16

(29.1)

0.85

(0.40 to 1.82)

  1. GP = general practitioner; OR = odds ratio; CI = confidence interval.
  2. *Excluding oseltamivir prescriptions.